Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium

Research in Microbiology

Volumn 148, Issue 8, 1997, Pages 673-681

  Horgen, L ^a   Legrand, E ^a   Rastogi, N ^a  

^a Unite de la Tuberculose et des Mycobacteries   (Guadeloupe)

Author keywords

Amikacin; Clarithromycin; Clofazimine; Mycobacterium avium; Postantibiotic effect; Rifampin; Sparfloxacin

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CLARITHROMYCIN; CLOFAZIMINE; RIFAMPICIN; SPARFLOXACIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

EID: 0030784455     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2508(99)80066-7     Document Type: Article

References (43)

1. Agnis, B.D., Berman, D.S., Spicehandler, D., El-Sadr, W., Simberkoff, M.S. & Rahal, J.J. (1989), Effect of combined therapy with anasamycin, clozazimine, ethambutol and isoniazid for Mycobacterium avium infection in patients with AIDS. J. Infect. Dis., 159, 784-787.
2. Baradelli, L.B., McTavish, D. & Plosker, G.L. (1993), Clarithromycin. Drugs, 46, 289-312.
3. Baron, E.J. & Young, L.S. (1986), Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with AIDS. Diagn. Microbiol. Infect. Dis., 5, 215-220.
4. Beggs, W.H. & Jenne, J.W. (1969), Isoniazid uptake and growth inhibition of Mycobacterium tuberculosis in relation to time and concentration of pulsed drug exposure. Tubercle, 50, 377-385.
5. Bermudez, L.E., Young, L.S., Wu, M. & Inderlied, C.B. (1992), Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex. J. Infect. Dis., 166, 923-926.
6. Buntzen, R.W., Cohn, D.L., Gerber, A.U. & Craig, W.A. (1981), Postantibiotic suppression of bacterial growth. Rev. Infect. Dis., 3, 28-37.
7. Chaisson, R.E., Keiser, P., Pierce, M., Jeffrey Fessel, W., Ruskin, J., Lahart, C., Benson, C.A., Meek, K., Siepman, N. & Carl Craft, J. (1997), Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. AIDS, 11, 311-317.
8. Chiu, J., Nussbaum, J., Bozettz, S., Tilles, J.G., Young, L.S., Leedom, J., Heseltine, P.N.R., McCutchan, J.A. & the California Collaborative Treatment Group. (1990), Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann. Intern. Med., 113, 358-361.
9. Craig, W.A. & Gudmundsson, S. (1991), Postantibiotic effect, in "Antibiotics in laboratory medecine", 3th edition. V. Lorian (ed.), (pp. 403-431). Williams & Wilkins, Baltimore, MD.
10. Daikos, D.K. (1991), Continuous versus discontinous antibiotic therapy: the role of the post antibiotic effect and other factors. J. Antimicrob. Chemother., 27, 157-160.
11. David, H.L., Clavel-Sérès, S., Clément, F. & Goh, K.S. (1987), Uptake of selected antibacterial agents in Mycobacterium avium. Zbl. Bakt. Hyg. A, 265, 385-392.
12. Dickinson, J.M. & Mitchinson, D.A. (1966), In vitro studies of the choice of drugs for intermittent chemotherapy of tuberculosis. Tubercle, 47, 370-380.
13. Eagle, H. (1949), The recovery of bacteria from the toxic effects of penicillin. J. Clin. Invest., 28, 832-836.
14. Ellis, L.C., Benson, C.A., Koenig, G.I. & Trenholme, G.M. (1995), Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex. Antimicrob. Agents Chemother., 39, 2803-2806.
15. Fantin, N.B., Ebert, J., Legerett, J., Vogelman, B. & Craig, W.A. (1990), Factors affecting duration of in vivo postantibiotic effect for aminoglycosides against Gram-negative bacilli. J. Antimicrob. Chemother., 27, 829-836.
16. Gerber, A.U. & Craig, W.A. (1981), Growth kinetic of respiratory pathogens after short exposures to ampicillin and erythromycin. J. Antimicrob. Chemother., 8, S81-S91.
17. Gudmundsson, A., Gottfredsson, M., Erlendstottir, H. & Gudmundsson, S. (1991), Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob. Agents. Chemother., 35, 2617-2624.
18. Heifets, L.B. (1994), Antimycobacterial drugs. Semin. Respir. Infect., 9, 84-103.
19. Heifets, L.B., Flory, M.A. & Lindholm-Levy, P.J. (1990), Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and M. tuberculosis. Am. Rev. Respir. Dis., 141, 626-630.
20. Hoy, J., Mijch, A., Sandland, M., Grayson, L., Lucas, R. & Dwyer, B. (1990), Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J. Infect. Dis., 161, 801-805.
21. Ji, B., Lounis, N., Truffot-Pernot, C. & Grosset, J. (1994), Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrob. Agents Chemother., 38, 2521-2529.
22. Kemper, C.A., Havlir, D., Haghighat, D., Dubé, M., Bartok, A.E., Sison, J.P., Yao, Y., Yangco, B., Leedom, J.M., Tilles, J.G., McCutchan, J.A. & Deresinski, S.C. (1994), The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J. Infect. Dis., 170, 157-164.
23. Lorian, V., Amaral, L. & Ernst, J. (1989), The postantibiotic effect defined by bacterial morphology. J. Antimicrob. chemother., 23, 485-91.
24. McDonald, P.J., Kunin, C.M. & Craig, W.A. (1977), Persistent effect of antibiotics on Staphylococus aureus after exposure for limited period of time. J. Infect. Dis., 135, 217-233.
25. McDonald, P.J., Pruul, H. & Weterhall, B.L. (1981), Postantibiotic leukocyte enhancement: increased suceptibility of bacteria pretreated with antibiotics to activity to leukocyte. Rev. Infec. Dis., 3, 38-44.
26. Mitchinson, D.A. & Dickinson, J.M. (1971), Laboratory aspects of intermittent drug therapy. Postgrad. Med. J., 47, 737-741.
27. Odenholt-Torqvist, I., Lowdin, E. & Cars, O. (1992), Postantibiotic sub-MIC effects of vancomycin, rothrixomycin, sparfloxacin and amikacin. Antimicrob. Agents Chemother., 36, 1852-1858.
28. Parker, R.F. & Luse, S. (1946), The action of penicillin on Staphylococcus aureus: further observations on the effect of a short exposure. J. Bacteriol., 56, 75-84.
29. Pruul, H., Lewis, G. & McDonald, P.J. (1988), Enhanced susceptibility of Gram-negative bacteria to phagocytic killing by human polymophonuclear leukocytes after brief exposure to aztreonam. J. Antimicrob. Chemother., 22, 675-686.
30. Rastogi, N. (1993), Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy, in "Antimicrobial Agents and Intracellular Pathogens" D. Raoult (ed.) (pp. 245-300). CRC Press, Boca Raton.
31. Rastogi, N., Barrow, W.W., Thoen, C.O., Crawford, J.T., Mangura, B.T., Reichman, L.B., Heifets, L.B., Dautzenberg, B., Young, L.S., Bermudez, L.E.M., Inderlied, C.B., Suzuki, A.E., Inamine, J.M., Gangadharam, P.R.J., Reddy, M.V., Denis, M., Shiratsuchi, H., Johnson, J.L., Ellner, J.J., Belisle, J.T. & Brennan, P.J. (1994), in "11th Forum in Microbiology: Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity". Res. Microbiol., 145, 167-261.
32. Rastogi, N., Falkinham, J.O., Grosset, J., Benson, C.A., Von Reyn, C.F., Pestel, M., Arbeit, R.D., Wallace, R.J. Jr, Sacchettini, J.C., Blanchard, J.S., Warek, U., Cole, ST., Cambau, E., Jarlier, V., Sander, P., Meier, A., Böttger, E.C., Morris, S.L., Rouse, D.A., Telenti, A., Persing, D.H., Gordon, S., Houldsworth, S., Duncan, K., Roberts, I.S., Andrew, P.W., Klopman, G., Fercu, D., Li, J.-Y., Rosenkranz, H.S., Jacobs, M.R., Goh, K.S., Van Ginkel, S.Z., Wright, E.L., Barrow, W.W., Maddry, J.A., Sulinh, W.J. & Reynolds, R.C. (1996), in "13th Forum in Microbiology: Solving the dilemma of antimycobacterial chemotherapy". Res. Microbiol., 147, 7-121.
33. Rastogi, N., Bourguoin, A., Bauriaud, R.M., Carbonnelle, B., Chippaux, C., Gevaudan, M.J., Goh, K.S., Moinard, D. & Roos, P. (1995), Frenche multicenter study involving eight test sites for radiometric determination of activities of ten antimicrobial agents against Mycobacterium avium complex. Antimicrob. Agents. Chemother., 39, 638-644.
34. Rastogi, N. & Goh, K.S. (1991), In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4110) against Mycobacterium tuberculosis compared with activities of oxfloxacin and ciproflaxin. Antimicrob. Agents Chemother., 35, 1933-1936.
35. Rastogi, N., Goh, K.S., Labrousse, V. & Carvalho de Sousa, J.P. (1991), Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob. Agents Chemother., 35, 2473-2480.
36. Rastogi, N. & Labrousse, V. (1991), Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium. Antimicrob. Agents Chemother., 35, 462-470.
37. Saito, H., Tomioka, H., Sato, K., Emori, M., Yamane, T., Yamashita, K., Hosoe, K. & Hidaka, T. (1991), In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. Antimicrob. Agents Chemother., 35, 542-547.
38. Truffot-Pernot, C., Grosset, J. & Ji, B. (1991), Effect of pH on the in vitro potency of clarithromycin againts Mycobacterium avium complex. Antimicrob. Agents Chemother., 35, 1677-1678.
39. Tsui, S.Y.T., Li, M.S.K., Yew, W.W., Chan, C.Y. & Cheng, A.F.B. (1993), Postantiobiotic effects of amikacin and oxofloxacin on Mycobacterium fortuitum. Antimicrob. Agents Chemother., 37, 1001-1003.
40. Tuomanen, E. (1986), Newly made enzymes determine ongoing cell wall synthesis and the bacterial effects of cell wall synthesis inhibitor. J. Bacteriol., 167, 535-543.
41. Vogelman, B.S. & Craig, W.A. (1989), Posantibiotic effect. J. Antimicrob. Chemother., 15, 37-46.
42. Warek, U. & Falkinham, J.O. III (1996), Action of clofazimine on the Mycobacterium avium complex. Res. Microbiol., 147, 43-48.
43. Wilson, D.A. & Rolinson, G.N. (1979), The recovery period following exposure of bacteria to penicillins. Chemotherapy, 25, 14-22.